Andrei Ungureanu

1.1k total citations
10 papers, 134 citations indexed

About

Andrei Ungureanu is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Andrei Ungureanu has authored 10 papers receiving a total of 134 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 2 papers in Molecular Biology and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Andrei Ungureanu's work include PARP inhibition in cancer therapy (2 papers), vaccines and immunoinformatics approaches (1 paper) and SARS-CoV-2 and COVID-19 Research (1 paper). Andrei Ungureanu is often cited by papers focused on PARP inhibition in cancer therapy (2 papers), vaccines and immunoinformatics approaches (1 paper) and SARS-CoV-2 and COVID-19 Research (1 paper). Andrei Ungureanu collaborates with scholars based in Romania, Italy and United States. Andrei Ungureanu's co-authors include Hugo Aguilaniu, Steffen Fehrmann, Gilles Charvin, C Paoletti, Youlian Goulev, Harrison Hong, Roberto Rosa, Anna María Ferrari, Roberto Giovanardi and Paolo Neri and has published in prestigious journals such as Green Chemistry, Cell Reports and ACS Sustainable Chemistry & Engineering.

In The Last Decade

Andrei Ungureanu

7 papers receiving 133 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Andrei Ungureanu Romania	5	74	44	18	17	16	10	134
Liam Gaul United Kingdom	3	213 2.9×	7 0.2×	6 0.3×	10 0.6×		3	247
Simone Di Sanzo Germany	5	86 1.2×	10 0.2×	5 0.3×	11 0.6×		7	121
Anna Kirillova United States	5	70 0.9×	10 0.2×	1 0.1×	9 0.5×		9	117
Árpád Bálind Hungary	5	74 1.0×	5 0.1×	3 0.2×	24 1.4×		5	121
Munazah Andrabi Japan	8	145 2.0×	4 0.1×	6 0.3×	4 0.2×		11	155
Yuko Kitano Japan	5	74 1.0×	6 0.1×	3 0.2×	9 0.5×		5	98
Sneha Gopalan United States	6	194 2.6×	4 0.1×	5 0.3×	4 0.2×		6	215
Daniel I. Resnicow United States	4	183 2.5×	4 0.1×	4 0.2×	17 1.0×		4	230
Richoo B. Davis United States	6	212 2.9×	2 0.0×	14 0.8×	10 0.6×		7	238
Teddy Yang China	2	156 2.1×	22 0.5×		5 0.3×		3	179

Countries citing papers authored by Andrei Ungureanu

Since Specialization

Citations

This map shows the geographic impact of Andrei Ungureanu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrei Ungureanu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrei Ungureanu more than expected).

Fields of papers citing papers by Andrei Ungureanu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrei Ungureanu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrei Ungureanu. The network helps show where Andrei Ungureanu may publish in the future.

Co-authorship network of co-authors of Andrei Ungureanu

This figure shows the co-authorship network connecting the top 25 collaborators of Andrei Ungureanu. A scholar is included among the top collaborators of Andrei Ungureanu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrei Ungureanu. Andrei Ungureanu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

1.

Ungureanu, Andrei, Antonella Sola, Paolo Neri, Roberto Rosa, & Anna María Ferrari. (2025). Systematic life cycle assessment of cobalt-based blue ceramic pigments: evaluating CoAl₂O₄ and lower-cobalt alternatives. Green Chemistry. 27(41). 12946–12958.

2.

Gray, Jhanelle E., Michael Schenker, Mehmet Alı Nahıt Şendur, et al.. (2024). The Phase 3 KEYLYNK-006 Study of Pembrolizumab Plus Olaparib Versus Pembrolizumab Plus Pemetrexed as Maintenance Therapy for Metastatic Nonsquamous NSCLC. Journal of Thoracic Oncology. 20(2). 219–232. 6 indexed citations

3.

Ungureanu, Andrei, et al.. (2024). Systematic Life Cycle Environmental Impact Comparison of Alternative Synthetic Strategies for Ti₃C₂T_x MXene. ACS Sustainable Chemistry & Engineering. 12(15). 5893–5906. 19 indexed citations

4.

Oprean, Cristina, et al.. (2022). Attitudes towards COVID‑19 vaccination in patients with cancer: A cross‑sectional study of 12 oncology centers. Molecular and Clinical Oncology. 17(6). 162–162. 2 indexed citations

5.

Chirilă, Magdalena, et al.. (2022). Sinonasal malignant melanoma. 12(47). 135–139.

6.

Chiorean, Angelica, et al.. (2019). Invasive bilateral breast cancer and high grade serous ovarian cancer with BRCA1-germline mutation and brainstem metastasis under PARP inhibitors. PubMed. 6(3). 69–75.

7.

Bințințan, Vasile, Romeo Chira, Andrei Pop, et al.. (2018). The Value of Staging Laparoscopy for Optimal Multidisciplinary Treatment in Patients with Gastric Cancer. Chirurgia. 113(6). 789–789. 5 indexed citations

8.

Fehrmann, Steffen, C Paoletti, Youlian Goulev, et al.. (2013). Aging Yeast Cells Undergo a Sharp Entry into Senescence Unrelated to the Loss of Mitochondrial Membrane Potential. Cell Reports. 5(6). 1589–1599. 84 indexed citations

9.

Hong, Harrison, et al.. (2011). An Epidemiological Approach to Opinion and Price-Volume Dynamics. SSRN Electronic Journal. 17 indexed citations

10.

Ungureanu, Andrei, et al.. (2010). [Splenic angioembolization--a safe, efficient and rational approach].. PubMed. 105(2). 243–8. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact